Heart Disease and Erectile Dysfunction / Edition 1

Heart Disease and Erectile Dysfunction / Edition 1

by Robert Kloner
     
 

ISBN-10: 1588292169

ISBN-13: 9781588292162

Pub. Date: 03/05/2004

Publisher: Springer-Verlag New York, LLC

This book will educate physicians treating men with erectile dysfunction (ED) about the risks of cardiovascular disease with the various treatment regimens for ED. It provides a framework for ED therapy in relationship to the cardiac patient, offering recent consensus guidelines on explaining the risks involved and treating the patient.

Overview

This book will educate physicians treating men with erectile dysfunction (ED) about the risks of cardiovascular disease with the various treatment regimens for ED. It provides a framework for ED therapy in relationship to the cardiac patient, offering recent consensus guidelines on explaining the risks involved and treating the patient.

Product Details

ISBN-13:
9781588292162
Publisher:
Springer-Verlag New York, LLC
Publication date:
03/05/2004
Series:
Contemporary Cardiology Series
Edition description:
2004
Pages:
300
Product dimensions:
6.10(w) x 9.25(h) x 0.03(d)

Table of Contents

Physiology of Erection and Causes of Erectile Dysfunction
Aristotelis G. Anastasiadis, Dmitry Droggin, Martin Burchardt, and Ridwan Shabsigh

Erectile Dysfunction: The Scope of the Problem
Culley C. Carson

Erectile Dysfunction and Cardiovascular Risk Factors
Robert A. Kloner

Psychologic Aspects of Erectile Dysfunction in Heart Patients
Raymond C. Rosen

Management of Erectile Dysfunction: An Overview
Harin Padma-Nathan

Sildenafil Citrate and the Nitric Oxide/Cyclic Guanosine Monophosphate Signaling Pathway
Ian H. Osterloh and Stephen C. Phillips

Phosphodiesterase-5 Inhibition: Importance to the Cardiovascular System
Jackie D. Corbin, Stephen R. Rannels, and Sharron H. Francis

The Hemodynamics of Phosphodiesterase-PDE5 Inhibitors
Graham Jackson

Cardiovascular Safety of Phosphodiesterase-5 Inhibitors
Robert A. Kloner

Effect of Phosphodiesterase-5 Inhibition on Coronary Blood Flow in Experimental Animals
YingJie Chen, Jay H. Traverse, and Robert J. Bache

Safety and Hemodynamic Effects of Sildenafil in Patients With Coronary Artery Disease
Sameer Rohatgi and Howard C. Herrmann

Cardiovascular Effects of Nonphosphodiesterase-5 Inhibitor Erectile Dysfunction Therapies
Harin Padma-Nathan

Potential Cardiac Applications of Phosphodiesterase Type-5 Inhibition
Michael Sweeney and Richard L. Siegel

The Physiologic Cost of Sexual Activity
Robert F. DeBusk

Sexual Activity As a Trigger of Myocardial Infarction/Ischemia: Implications for Treating Erectile Dysfunction
Robert A. Kloner

Sex After Cardiac Events and Procedures: Counseling From the Cardiovascular Specialist's Perspective
Herman A. Taylor, Jr.

American College of Cardiology/American Heart Association Guidelines on the Use of Sildenafil in Patients With Cardiovascular Disease
Adolph M. Hutter, Jr.

Risk of Heart Attack After Sexual Activity: The Princeton Guidelines and Their Rationale
Robert F. DeBusk

Index

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >